Regional News Archives - Page 184 of 186 - Journal for Clinical Studies

Current Edition

Asia Pacific

Teva, Takeda add details on new venture in Japan

The independent company being created by a joint venture between Israel's Teva Pharmaceutical Industries ($TEVA) and Japan's Takeda Pharmaceutical became a bit more c...

6 January 2016 Asia Pacific | Regional News

Continue Reading →

Europe

Exco InTouch announces the demonstration of equivalence for EQ-5D-5L

ScHARR completes independent, scientific, peer reviewed study, funded by Exco InTouch, comparing EQ-5D-5L equivalence across mobile phone and paper administration mod...

10 December 2015 Europe | Regional News

Continue Reading →

news

A New Approach to Revolutionize Clinical Trials

It may be the biggest thing in medicine in a long time. It's not a new drug, or therapy or discovery. Instead it's a new way of doing clinical trials which could have...

9 December 2015 news | North America | Regional News

Continue Reading →

news

Antidepressant with novel action appears safe, effective in clinical trial

December 8, 2015 - A small clinical trial of a novel antidepressant that stimulates neurogenesis -- the production of new brain cells -- shows that the compound appea...

9 December 2015 news | North America | Regional News

Continue Reading →

news

Aduro Biotech Says All Clinical Trials Will Continue Unaltered and as Planned

Aduro Biotech (ADRO), a clinical-stage immunotherapy company, confirmed late Tuesday that it will continue all its clinical trials unaltered and as planned. The annou...

25 November 2015 news | North America | Regional News

Continue Reading →

news

Clinical trial could lead to new bladder cancer drug

A bladder cancer drug tested in a University of Hawai'i Cancer Center clinical trial is getting closer to Food and Drug Administration (FDA) approval. The new drug, ...

25 November 2015 news | North America | Regional News

Continue Reading →

news

Otonomy Initiates Phase 1 Clinical Trial for Tinnitus Product Candidate, OTO-311

SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization ...

17 November 2015 news | North America | Regional News

Continue Reading →

news

Clinical Trial Data Underreported: Study

One-third of the human experiments for approved drugs failed transparency requirements. Volunteers for clinical trials shouldn’t get their hopes up too high that dat...

17 November 2015 news | North America | Regional News

Continue Reading →

Europe

MLM Medical Labs and Cenetron Central Laboratories Announce Strategic Alliance

Central laboratories expand transcontinental reach with integrated services Moenchengladbach, Germany and Austin, Texas, USA - November 11, 2015 MLM Medica...

11 November 2015 Europe | news | North America | Regional News

Continue Reading →

news

NeuroGenetic Pharmaceuticals Awarded $2.5 Million Grant From NIA to Conduct Clinical Trials with NGP 555 to Treat and Prevent Alzheimer’s Disease; Reports Initial Results of Phase 1a Clinical Trial

SAN DIEGO/November 10, 2015 --(BUSINESS WIRE)--NeuroGenetic Pharmaceuticals, Inc. (NGP), a privately held biopharmaceutical company focused on Alzheimer’s disease (AD...

11 November 2015 news | North America | Regional News

Continue Reading →